BioSpace News Archive

Press Releases

ORIC® Pharmaceuticals Presented Preclinical Data at the EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics Supporting Best-in-Class Potential of ORIC-944 to Treat Patients With Prostate Cancer and Other Solid Tumors

October 28, 2025
·
7 min read
Press Releases

SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $31 Million in Gross Proceeds

October 28, 2025
·
4 min read
Press Releases

Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing

October 28, 2025
·
6 min read
Press Releases

New Study Demonstrates Accuracy of Two Quest AD-Detect® Tests for Alzheimer’s Disease Diagnosis

October 28, 2025
·
4 min read
Press Releases

Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025

October 28, 2025
·
3 min read
Press Releases

Xenon to Report Q3 2025 Financial Results on November 3, 2025

October 28, 2025
·
1 min read
Press Releases

Amarin Issues Statement Supporting FDA’s Action to Revise Labeling for Fenofibrate Drugs Reinforcing a Lack of Cardiovascular Benefit

October 28, 2025
·
11 min read
Press Releases

Centers for Medicare and Medicaid Services Assigns Permanent J Code for ZUSDURI™ Effective January 1, 2026

October 28, 2025
·
8 min read
Press Releases

New study reveals substantial unmet need in psoriasis, shows strong patient and provider preference for highly effective oral treatments with favorable safety profile

October 28, 2025
·
6 min read
Press Releases

Revolution Medicines’ RAS(ON) Multi-Selective Inhibitor Daraxonrasib Granted U.S. FDA Orphan Drug Designation in Pancreatic Cancer

October 28, 2025
·
6 min read